Global Primary Biliary Cirrhosis Drug Market Analysis 2013-2018 and Forecast 2019-2024

Table of Contents

1 Industry Overview

• 1.1 Primary Biliary Cirrhosis Drug Industry
  • 1.1.1 Overview
  • 1.1.2 Development of Primary Biliary Cirrhosis Drug
• 1.2 Market Segment
  • 1.2.1 Upstream
  • 1.2.2 Downstream
• 1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

• 2.1 Policy
• 2.2 Economics
• 2.3 Sociology
• 2.4 Technology

3 Primary Biliary Cirrhosis Drug Market by Type

• 3.1 By Type
  • 3.1.1 Budesonide
  • 3.1.2 FFP-104
  • 3.1.3 GSK-2330672
  • 3.1.4 MBX-8025
  • 3.1.5 NGM-282
  • 3.1.6 Others
• 3.2 Market Size
• 3.3 Market Forecast

4 Major Companies List

4.Primary Biliary Cirrhosis Drug AlbireoPharma (Company Profile, Sales Data etc.)

• 4.2 CymaBay Therapeutics, Inc. (Company Profile, Sales Data etc.)
• 4.3 Dr. Falk Pharma GmbH (Company Profile, Sales Data etc.)
• 4.4 Enanta Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)
• 4.5 GlaxoSmithKline Plc (Company Profile, Sales Data etc.)
• 4.6 Intercept Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)
• 4.7 Johnson & Johnson (Company Profile, Sales Data etc.)
• 4.8 MediGene AG (Company Profile, Sales Data etc.)
• 4.9 NGM Biopharmaceuticals, Inc. (Company Profile, Sales Data etc.)
• 4.10 Virobay Inc. (Company Profile, Sales Data etc.)

5 Market Competition

• 5.1 Company Competition
• 5.2 Regional Market by Company

6 Demand by End Market

• 6.1 Demand Situation
  • 6.1.1 Demand in Clinic
  • 6.1.2 Demand in Hospital
  • 6.1.3 Demand in Others
• 6.2 Regional Demand Comparison
• 6.3 Demand Forecast

7 Region Operation

• 7.1 Regional Production
• 7.2 Regional Market
• 7.3 by Region
  • 7.3.1 North America
    • 7.3.1.1 Overview
    • 7.3.1.2 by Country (U.S., Canada, Mexico)
  • 7.3.2 Europe
    • 7.3.2.1 Overview
    • 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
  • 7.3.3 Asia-Pacific
    • 7.3.3.1 Overview
    • 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
  • 7.3.4 South America
    • 7.3.4.1 Overview
    • 7.3.4.2 by Country (Brazil, Argentina etc.)
  • 7.3.5 Middle East & Africa
    • 7.3.5.1 Overview
    • 7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
• 7.4 Regional Import & Export
• 7.5 Regional Forecast

8 Marketing & Price

• 8.1 Price and Margin
  • 8.1.1 Price Trends
  • 8.1.2 Factors of Price Change
  • 8.1.3 Manufacturers Gross Margin Analysis
• 8.2 Marketing Channel

9 Research Conclusion

List of Tables

Table Upstream Segment of Primary Biliary Cirrhosis Drug

Table Application Segment of Primary Biliary Cirrhosis Drug

Table Global Primary Biliary Cirrhosis Drug Market 2013-2024, by Application, in USD Million

Table Major Company List of Budesonide

Table Major Company List of FFP-104

Table Major Company List of GSK-2330672

Table Major Company List of MBX-8025

Table Major Company List of NGM-282

Table Major Company List of Others

Table Global Primary Biliary Cirrhosis Drug Market 2013-2018, by Type, in USD Million

Table Global Primary Biliary Cirrhosis Drug Market 2013-2018, by Type, in Volume

Table Global Primary Biliary Cirrhosis Drug Market Forecast 2019-2024, by Type, in USD Million

Table Global Primary Biliary Cirrhosis Drug Market Forecast 2019-2024, by Type, in Volume

Table AlbireoPharma Overview List

Table Primary Biliary Cirrhosis Drug Business Operation of AlbireoPharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table CymaBay Therapeutics, Inc. Overview List

Table Primary Biliary Cirrhosis Drug Business Operation of CymaBay Therapeutics, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Dr. Falk Pharma GmbH Overview List

Table Primary Biliary Cirrhosis Drug Business Operation of Dr. Falk Pharma GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Enanta Pharmaceuticals, Inc. Overview List

Table Primary Biliary Cirrhosis Drug Business Operation of Enanta Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table GlaxoSmithKline Plc Overview List

Table Primary Biliary Cirrhosis Drug Business Operation of GlaxoSmithKline Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Intercept Pharmaceuticals, Inc. Overview List

Table Primary Biliary Cirrhosis Drug Business Operation of Intercept Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Johnson & Johnson Overview List

Table Primary Biliary Cirrhosis Drug Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table MediGene AG Overview List

Table Primary Biliary Cirrhosis Drug Business Operation of MediGene AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table NGM Biopharmaceuticals, Inc. Overview List

Table Primary Biliary Cirrhosis Drug Business Operation of NGM Biopharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Virobay Inc. Overview List

Table Primary Biliary Cirrhosis Drug Business Operation of Virobay Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Primary Biliary Cirrhosis Drug Sales Revenue 2013-2018, by Company, in USD Million

Table Global Primary Biliary Cirrhosis Drug Sales Revenue Share, by Company, in USD Million

Table Global Primary Biliary Cirrhosis Drug Sales Volume 2013-2018, by Company, in Volume

Table Global Primary Biliary Cirrhosis Drug Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Primary Biliary Cirrhosis Drug Demand Forecast 2019-2024, by Application, in USD Million

Table Primary Biliary Cirrhosis Drug Demand Forecast 2019-2024, by Application, in Volume

Table Primary Biliary Cirrhosis Drug Production 2013-2018, by Region, in USD Million

Table Primary Biliary Cirrhosis Drug Production 2013-2018, by Region, in Volume

Table Global Primary Biliary Cirrhosis Drug Market 2013-2018, by Region, in USD Million

Table Global Primary Biliary Cirrhosis Drug Market Share 2013-2018, by Region, in USD Million

Table Global Primary Biliary Cirrhosis Drug Market 2013-2018, by Region, in Volume

Table Global Primary Biliary Cirrhosis Drug Market Share 2013-2018, by Region, in Volume

Table North America Primary Biliary Cirrhosis Drug Market Size 2013-2018, by Country, in USD Million

Table North America Primary Biliary Cirrhosis Drug Market Size 2013-2018, by Country, in Volume

Table Europe Primary Biliary Cirrhosis Drug Market Size 2013-2018, by Country, in USD Million

Table Europe Primary Biliary Cirrhosis Drug Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Primary Biliary Cirrhosis Drug Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Primary Biliary Cirrhosis Drug Market Size 2013-2018, by Country, in Volume

Table South America Primary Biliary Cirrhosis Drug Market Size 2013-2018, by Country, in USD Million

Table South America Primary Biliary Cirrhosis Drug Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Primary Biliary Cirrhosis Drug Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Primary Biliary Cirrhosis Drug Market Size 2013-2018, by Country, in Volume

Table Primary Biliary Cirrhosis Drug Market Forecast 2019-2024, by Region, in USD Million

Table Primary Biliary Cirrhosis Drug Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

List of Figures

Figure Global Primary Biliary Cirrhosis Drug Market Growth 2013-2018, by Type, in USD Million

Figure Global Primary Biliary Cirrhosis Drug Market Growth 2013-2018, by Type, in Volume

Figure North America Primary Biliary Cirrhosis Drug Market Concentration, in 2018

Figure Europe Primary Biliary Cirrhosis Drug Market Market Concentration, in 2018

Figure Asia-Pacific Primary Biliary Cirrhosis Drug MMarket Concentration, in 2018

Figure South America Primary Biliary Cirrhosis Drug Market Concentration, in 2018

Figure Middle East & Africa Primary Biliary Cirrhosis Drug Market Concentration, in 2018

Figure Primary Biliary Cirrhosis Drug Demand in Clinic, 2013-2018, in USD Million

Figure Primary Biliary Cirrhosis Drug Demand in Clinic, 2013-2018, in Volume

Figure Primary Biliary Cirrhosis Drug Demand in Hospital, 2013-2018, in USD Million

Figure Primary Biliary Cirrhosis Drug Demand in Hospital, 2013-2018, in Volume

Figure Primary Biliary Cirrhosis Drug Demand in Others, 2013-2018, in USD Million

Figure Primary Biliary Cirrhosis Drug Demand in Others, 2013-2018, in Volume

Figure North America Primary Biliary Cirrhosis Drug Market Size and Growth 2013-2018, in USD Million

Figure North America Primary Biliary Cirrhosis Drug Market Size and Growth 2013-2018, in Volume

Figure Europe Primary Biliary Cirrhosis Drug Market Size and Growth 2013-2018, in USD Million

Figure Europe Primary Biliary Cirrhosis Drug Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Primary Biliary Cirrhosis Drug Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Primary Biliary Cirrhosis Drug Market Size and Growth 2013-2018, in Volume

Figure South America Primary Biliary Cirrhosis Drug Market Size and Growth 2013-2018, in USD Million

Figure South America Primary Biliary Cirrhosis Drug Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Primary Biliary Cirrhosis Drug Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Primary Biliary Cirrhosis Drug Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview